Equity Research Associate - Cardiology, Endocrine Radiopharmaceuticals

Position: Equity Research Associate - Cardiology, Endocrine, ID, Radiopharmaceuticals
Location: New York
*
* Reports to:

** Sr. Equity Research Analyst
** Department:
** Equity Research
*
* Location:

** New York
** Salary Range:** $110,000-$150,000

We are seeking a highly talented individual to add significant value to our equity research team. This individual will work directly with a Senior Managing Director to assist in preparing and executing analyses of specific areas within biotechnology, with a focus on commercial and clinical stage companies across a wide range of therapy areas: cardiology, endocrine, , radiopharmaceuticals. The ideal candidate will have an innovative mindset, relentless intellectual curiosity, passion for biotech innovation and the stock market, and be a steadfast team player in a fast-paced environment.

Previous sell-side associate experience is strongly preferred.
*
* Primary Duties and Responsibilities:

*** Formulate investment recommendations based on fundamental analysis, valuation and risk assessment of individual companies
* Leverage scientific and financial mindset in writing research reports on companies for distribution to the Leerink sales force and institutional clients
* Collect and analyze data (i.e., scientific papers, clinical trial data) related to novel therapeutics in immunologic diseases
* Interview company executives and medical/industry experts to develop and maintain sources of information in preparation of analyses
* Build, update and maintain financial models to inform investment recommendations
* Keep up to date on all sector-relevant market news and medical meeting presentations
* Answer inquiries from firm personnel and external clients
* Support senior equity research professionals by attending events of special interest (i.e., medical conferences, investor meetings)
*
* Experience and Qualifications:

*** Qualified candidates must be hard-working self-starters with a passion for leveraging their medical/scientific background & financial modeling skills towards equity research
* Prior industry/business experience required: 1+ years of experience in sell-side equity research role strongly preferred, or 1+ years of experience in investment banking, VC / private equity, buy-side biotech investment, or top consulting firm role.
* Medical or scientific background a plus: MS, PhD or MD preferred
* Fully licensed is a plus:
Completion of all exams (SIE, Series 86/87, Series 63) is preferred
* Familiarity and knowledge of the biotechnology and pharmaceutical industries including clinical development, regulatory affairs, business development, and commercialization
* Excellent written & verbal communication skills and strong multi-tasking ability
* Ability to search, understand and synthesize scientific and medical publications
* Strong quantitative, financial modeling, forecasting and Excel skills
** Equal Employment Opportunity:
** Leerink Partners is an equal opportunity employer and is dedicated to expanding its commitments and investments to create a more diverse, equitable and inclusive company culture and innovation ecosystem. We are strongly committed to the values and policy of equal employment opportunity across our employment practices.

Actual starting base pay will be determined on skills, experience, and other non-discriminatory factors permitted by law. Total compensation may also include variable incentives, bonuses, benefits, and/or other perks, as outlined in any formal offer made.
*
* Job Title:

** Equity Research Associate – Cardiology, Endocrine, , Radiopharmaceuticals Leerink Partners is a leading investment bank providing a complete suite of financial solutions comprising M&A advisory, equity, debt, and derivative capital markets, equity research, and sales and trading capabilities. The firm’s strategic focus on the healthcare industry empowers it to provide unique advice and insights to its clients. The firm is a broker-dealer registered with the United States Securities and Exchange Commission and a member of the Financial Industry Regulatory Authority.
#J-18808-Ljbffr